InvestorsHub Logo
Followers 3
Posts 2048
Boards Moderated 1
Alias Born 11/02/2016

Re: exploremore post# 15919

Friday, 10/20/2023 5:24:21 AM

Friday, October 20, 2023 5:24:21 AM

Post# of 16556
Here is a bit from another one...



Aug 2019

"NanoLogix Seeks $3 Million For Expansion and Development

Offers Net-Revenue Share of N-Assay Bacteria Diagnostic

NanoLogix is discussing with domestic and international investment groups, and is seeking additional interested parties, for an investment offer of a net-revenue interest share of the N-Assay Bacteria Diagnostic and its planned associated Pretest. In exchange for an investment of up to $3 million, NanoLogix proposes a five-year 3-5% net-revenue sharing arrangement beginning with the proposed marketing rollout of the N-Assay in 2021, following planned patient studies in Houston. The funds are to be used for company expansion, development, production and marketing for the N-Assay, Pretest, and FlatPack petri plate technologies. There is no stock issuance or dilution involved with the funding proposal.